|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ethun CG, Postlewait LM, Le N, Pawlik TM,
Buettner S, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, et
al: Association of optimal time interval to Re-resection for
incidental gallbladder cancer with overall survival: A
multi-institution analysis from the US extrahepatic biliary
malignancy consortium. JAMA Surg. 152:143–149. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lopez-Aguiar AG, Ethun CG, McInnis MR,
Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC,
Krasnick BA, et al: Association of perioperative transfusion with
survival and recurrence after resection of gallbladder cancer: A
10-institution study from the US extrahepatic biliary malignancy
consortium. J Surg Oncol. 117:1638–1647. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Margonis GA, Gani F, Buettner S, Amini N,
Sasaki K, Andreatos N, Ethun CG, Poultsides G, Tran T, Idrees K, et
al: Rates and patterns of recurrence after curative intent
resection for gallbladder cancer: A multi-institution analysis from
the US extra-hepatic biliary malignancy consortium. HPB (Oxford).
18:872–878. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hundal R and Shaffer EA: Gallbladder
cancer: Epidemiology and outcome. Clin Epidemiol. 6:99–109.
2014.PubMed/NCBI
|
|
7
|
Baiu I and Visser B: Gallbladder Cancer.
JAMA. 320:12942018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barreto SG, Dutt A and Chaudhary A: A
genetic model for gallbladder carcinogenesis and its dissemination.
Ann Oncol. 25:1086–1097. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Valle JW, Lamarca A, Goyal L, Barriuso J
and Zhu AX: New horizons for precision medicine in biliary tract
cancers. Cancer Discov. 7:943–962. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Renfro LA, An MW and Mandrekar SJ:
Precision oncology: A new era of cancer clinical trials. Cancer
Lett. 387:121–126. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J and Liu H, Shen X, Wang Y, Zhang D,
Shen S, Suo T, Pan H, Ming Y, Ding K and Liu H: Long non-coding RNA
expression profiles in gallbladder carcinoma identified using
microarray analysis. Oncol Lett. 13:3508–3516. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sicklick JK, Fanta PT, Shimabukuro K and
Kurzrock R: Genomics of gallbladder cancer: The case for
biomarker-driven clinical trial design. Cancer Metastasis Rev.
35:263–75. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma MZ, Zhang Y, Weng MZ, Wang SH, Hu Y,
Hou ZY, Qin YY, Gong W, Zhang YJ, Kong X, et al: Long Noncoding RNA
GCASPC, a Target of miR-17-3p, negatively regulates pyruvate
carboxylase-dependent cell proliferation in gallbladder cancer.
Cancer Res. 76:5361–5371. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He Y, Xue C, Yu Y, Chen J, Chen X, Ren F,
Ren Z, Cui G and Sun R: CD44 is overexpressed and correlated with
tumor progression in gallbladder cancer. Cancer Manag Res.
10:3857–3865. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao X, Xu M, Cai Z, Yuan W, Cui W and Li
MD: Identification of LIFR, PIK3R1, and MMP12 as
novel prognostic signatures in gallbladder cancer using
network-based module analysis. Front Oncol. 9:3252019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Machida YJ, Machida Y, Chen Y, Gurtan AM,
Kupfer GM, D'Andrea AD and Dutta A: UBE2T is the E2 in the Fanconi
anemia pathway and undergoes negative autoregulation. Mol Cell.
23:589–96. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ramaekers CH, van den Beucken T, Meng A,
Kassam S, Thoms J, Bristow RG and Wouters BG: Hypoxia disrupts the
Fanconi anemia pathway and sensitizes cells to chemotherapy through
regulation of UBE2T. Radiother Oncol. 101:190–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang W, Zhang Y, Yang Z, Liu X, Yang P,
Wang J, Hu K, He X, Zhang X and Jing H: High expression of UBE2T
predicts poor prognosis and survival in multiple myeloma. Cancer
Gene Ther. 26:347–355. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mamrak NE, Shimamura A and Howlett NG:
Recent discoveries in the molecular pathogenesis of the inherited
bone marrow failure syndrome Fanconi anemia. Blood Rev. 31:93–99.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Perez-Peña J, Corrales-Sánchez V, Amir E,
Pandiella A and Ocana A: Ubiquitin-conjugating enzyme E2T (UBE2T)
and denticleless protein homolog (DTL) are linked to poor outcome
in breast and lung cancers. Sci Rep. 7:175302017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu LP, Yang M, Peng QZ, Li MY, Zhang YS,
Guo YH, Chen Y and Bao SY: UBE2T promotes hepatocellular carcinoma
cell growth via ubiquitination of p53. Biochem Biophys Res Commun.
493:20–27. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gong YQ, Peng D, Ning XH, Yang XY, Li XS,
Zhou LQ and Guo YL: UBE2T silencing suppresses proliferation and
induces cell cycle arrest and apoptosis in bladder cancer cells.
Oncol Lett. 12:4485–4492. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, Leng H, Chen H, Wang L, Jiang N,
Huo X and Yu B: Knockdown of UBE2T inhibits osteosarcoma cell
proliferation, migration, and invasion by suppressing the PI3K/Akt
signaling pathway. Oncol Res. 24:361–369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zahurak M, Parmigiani G, Yu W, Scharpf RB,
Berman D, Schaeffer E, Shabbeer S and Cope L: Pre-processing
Agilent microarray data. BMC Bioinformatics. 8:1422007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C
and Jensen LJ: STRING v9.1: Protein-protein interaction networks,
with increased coverage and integration. Nucleic Acids Res.
41((Database issue)): D808–D815. 2013.PubMed/NCBI
|
|
28
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bandettini WP, Kellman P, Mancini C,
Booker OJ, Vasu S, Leung SW, Wilson JR, Shanbhag SM, Chen MY and
Arai AE: MultiContrast Delayed Enhancement (MCODE) improves
detection of subendocardial myocardial infarction by late
gadolinium enhancement cardiovascular magnetic resonance: A
clinical validation study. J Cardiovasc Magn Reson. 14:832012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maere S, Heymans K and Kuiper M: BiNGO: A
Cytoscape plugin to assess overrepresentation of gene ontology
categories in biological networks. Bioinformatics. 21:3448–3449.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang DW, Sherman BT, Tan Q, Collins JR,
Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki
RA: The DAVID gene functional classification tool: A novel
biological module-centric algorithm to functionally analyze large
gene lists. Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: the 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miller RG Jr: What price Kaplan-Meier?
Biometrics. 39:1077–1081. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qiu Y, Luo X, Kan T, Zhang Y, Yu W, Wei Y,
Shen N, Yi B and Jiang X: TGF-β upregulates miR-182 expression to
promote gallbladder cancer metastasis by targeting CADM1. Mol
Biosyst. 10:679–685. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sharma A, Sharma KL, Gupta A, Yadav A and
Kumar A: Gallbladder cancer epidemiology, pathogenesis and
molecular genetics: Recent update. World J Gastroenterol.
23:3978–3998. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ethun CG, Postlewait LM, Le N, Pawlik TM,
Buettner S, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, et
al: A novel pathology-based preoperative risk score to predict
locoregional residual and distant disease and survival for
incidental gallbladder cancer: A 10-institution study from the U.S.
Extrahepatic biliary malignancy consortium. Ann Surg Oncol.
24:1343–1350. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shen H, He M, Lin R, Zhan M, Xu S, Huang
X, Xu C, Chen W, Yao Y, Mohan M and Wang J: PLEK2 promotes
gallbladder cancer invasion and metastasis through EGFR/CCL2
pathway. J Exp Clin Cancer Res. 38:2472019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Qin Y, Zhou Y, Ge A, Chang L, Shi H, Fu Y
and Luo Q: Overexpression of SNORA21 suppresses tumorgenesis of
gallbladder cancer in vitro and in vivo. Biomed Pharmacother.
118:1092662019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang L, Gao Q, Wu X, Feng F and Xu K: Long
noncoding RNA HEGBC promotes tumorigenesis and metastasis of
gallbladder cancer via forming a positive feedback loop with
IL-11/STAT3 signaling pathway. J Exp Clin Cancer Res. 37:1862018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Niu J, Li Z and Li F: Overexpressed
microRNA-136 works as a cancer suppressor in gallbladder cancer
through suppression of JNK signaling pathway via inhibition of
MAP2K4. Am J Physiol Gastrointest Liver Physiol. 317:G670–G681.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Manohar R, Li Y, Fohrer H, Guzik L, Stolz
DB, Chandran UR, LaFramboise WA and Lagasse E: Identification of a
candidate stem cell in human gallbladder. Stem Cell Res.
14:258–269. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kong L, Wu Q, Zhao L, Ye J, Li N and Yang
H: Identification of messenger and long noncoding RNAs associated
with gallbladder cancer via gene expression profile analysis. J
Cell Biochem. 120:19377–19387. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang J, Shao N, Ding X, Tan B, Song Q,
Wang N, Jia Y, Ling H and Cheng Y: Crosstalk between transforming
growth factor-β signaling pathway and long non-coding RNAs in
cancer. Cancer Lett. 370:296–301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Banning A, Babuke T, Kurrle N, Meister M,
Ruonala MO and Tikkanen R: Flotillins Regulate Focal Adhesions by
Interacting with α-Actinin and by Influencing the Activation of
Focal Adhesion Kinase. Cells. 7:282018. View Article : Google Scholar
|
|
47
|
Sharif T, Martell E, Dai C, Kennedy BE,
Murphy P, Clements DR, Kim Y, Lee PW and Gujar SA: Autophagic
homeostasis is required for the pluripotency of cancer stem cells.
Autophagy. 13:264–284. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yang L, Guo W, Zhang S and Wang G:
Ubiquitination-proteasome system: A new player in the pathogenesis
of psoriasis and clinical implications. J Dermatol Sci. 89:219–225.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Qiu J, Sheedlo MJ, Yu K, Tan Y, Nakayasu
ES, Das C, Liu X and Luo Z-Q: Ubiquitination independent of E1 and
E2 enzymes by bacterial effectors. Nature. 533:120–124. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kao SH, Wu HT and Wu KJ: Ubiquitination by
HUWE1 in tumorigenesis and beyond. J Biomed Sci. 25:672018.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Alpi AF, Chaugule V and Walden H:
Mechanism and disease association of E2-conjugating enzymes:
Lessons from UBE2T and UBE2L3. Biochem J. 473:3401–3419. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pagliarini R, Shao W and Sellers WR:
Oncogene addiction: Pathways of therapeutic response, resistance,
and road maps toward a cure. EMBO Rep. 16:280–296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Garraway LA, Verweij J and Ballman KV:
Precision oncology: An overview. J Clin Oncol. 31:1803–1805. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Tao Y, Li R, Shen C, Li J, Zhang Q, Ma Z,
Wang F and Wang Z: SENP1 is a crucial promotor for hepatocellular
carcinoma through deSUMOylation of UBE2T. Aging (Albany NY).
12:1563–1576. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Aloia TA, Jarufe N, Javle M, Maithel SK,
Roa JC, Adsay V, Coimbra FJ and Jarnagin WR: Gallbladder cancer:
Expert consensus statement. HPB (Oxford). 17:681–690. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Goetze TO and Paolucci V: Adequate extent
in radical re-resection of incidental gallbladder carcinoma:
Analysis of the German Registry. Surg Endosc. 24:2156–2164. 2010.
View Article : Google Scholar : PubMed/NCBI
|
